Benefits
Corrects Chromium Deficiency in TPN
Chromium chloride is used to supply chromium in intravenous and total parenteral nutrition. In rare deficiency cases arising during long-term parenteral nutrition, adding chromium has reversed glucose intolerance and related symptoms. That evidence is case-report evidence rather than controlled trials, and the report cited here describes one patient, in 1977. Chromium is nonetheless a standard component of parenteral trace-element solutions.
Glucose Metabolism Role
Chromium contributes to normal carbohydrate metabolism and insulin action. The foundational evidence for this role came from chromium chloride supplementation in deficient patients, although routine oral use shows little benefit in people who are not deficient.
Reference Inorganic Form
As the traditional inorganic chromium salt, chromium chloride served as the standard against which newer, better-absorbed chromium forms were compared. This historical role makes it a benchmark for understanding chromium bioavailability.
Parenteral Nutrition Component
Chromium chloride remains a practical, soluble source of chromium for compounding parenteral nutrition trace-element solutions, helping maintain adequate chromium status in patients who cannot eat normally.
Mechanism of action
Low Oral Absorption
Inorganic chromium chloride is absorbed very poorly from the gut (about 0.5-2%), which limits its usefulness as an oral supplement and is the main reason chelated forms such as picolinate were developed to improve uptake.
Insulin Signaling Support
Once absorbed or delivered intravenously, trivalent chromium is proposed to support insulin receptor signaling and glucose uptake, the basis for the improvement seen when chromium was restored in deficient parenteral-nutrition patients.
Direct Systemic Delivery via Infusion
Given intravenously in parenteral nutrition, chromium chloride bypasses poor intestinal absorption and delivers chromium directly to the circulation, which is why the historic deficiency-reversal evidence comes from this route.
Not an Established Essential Nutrient
Despite chromium's classic association with glucose tolerance, current analyses hold that chromium is not clearly essential and has no defined dietary deficiency in healthy people, consistent with the weak effects of oral chromium salts.
Clinical trials
Case report published in 1977 describing one patient: a 40-year-old woman who had been on total parenteral nutrition for more than five years and developed glucose intolerance, weight loss, and neuropathy. She received intravenous chromium chloride at 250 mcg per day for two weeks, then 20 mcg per day as maintenance, and was followed for 18 months. This is a single-patient observation, not a controlled trial.
One patient (n=1). A 40-year-old woman on total parenteral nutrition for more than five years.
Chromium supplementation reversed the glucose intolerance, reduced the need for insulin, and improved neuropathy and well-being. This historic case using chromium chloride helped establish chromium's role in glucose metabolism, and it remains genuinely important for that reason. It is also one person, reported in 1977, in a rare deficiency state produced by years of intravenous feeding. It says nothing about benefit in well-nourished people taking oral chromium.
Randomized, double-blind, placebo-controlled trial of chromium yeast providing 400 mcg of chromium per day versus placebo over 6 months, in Western patients with type 2 diabetes who were already taking oral glucose-lowering medication. The main outcome was HbA1c. Note the form: this trial tested chromium yeast, not chromium chloride.
Western type 2 diabetes patients on oral therapy.
No difference in HbA1c was found between chromium and placebo. The authors concluded, verbatim: "There is no evidence that chromium in the form of chromium yeast is effective in improving glycemic control in Western patients with type 2 diabetes who are taking oral hypoglycemic agents." That is direct evidence against a glycemic benefit for chromium yeast. Because chromium chloride was not the form tested, it is also not a direct test of chromium chloride. Beyond correcting frank deficiency, chromium supplementation has not shown a reliable glycemic benefit.